MarketCap
Facebook
X
TelegramAnnual report 2025
added 05-27-2026
ICON Public Limited Company Operating Cycle 2011-2026 | ICLR
Annual Operating Cycle ICON Public Limited Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63.4 | 70.4 | 79.2 | 72.5 | 68.5 | 81.1 | 61.5 | 56.3 | 83.4 | 145 | 148 | 134 | 131 | 141 | 135 | 73.6 | 39.5 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 148 | 39.5 | 93.1 |
Quarterly Operating Cycle ICON Public Limited Company
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q4 | 2009-Q4 | 2008-Q4 | 2007-Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 61.5 | - | - | 15.4 | - | - | - | 20.5 | - | - | - | - | - | - | 65.3 | - | 49.3 | 70 | 73.5 | - | 64 | 73.5 | 67.5 | - | 53.9 | 55.6 | 56.3 | - | 54.2 | 56.8 | 56.9 | - | 73 | 74.1 | 80.4 | - | 83.7 | 81 | 88.2 | - | 86.1 | 84.5 | 86.5 | - | 89 | 87.4 | 89.2 | - | 89.4 | 77.4 | 79.4 | - | 73.4 | 69.7 | 72.5 | - | 69.7 | 70.3 | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 89.4 | 15.4 | 69.4 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | USA |
 |
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 203.06 | -0.38 % | $ 22.5 B | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
1.79 K | $ 4.29 | -8.72 % | $ 5.71 M | USA |
 |
Fulgent Genetics
FLGT
|
87 | $ 18.68 | -0.53 % | $ 575 M | USA |
 |
Castle Biosciences
CSTL
|
97.4 | $ 20.7 | -1.48 % | $ 600 M | USA |
 |
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
128 | $ 131.62 | 0.55 % | $ 16.5 B | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 22.97 | -2.92 % | $ 1.22 B | USA |
 |
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | USA |
 |
Interpace Biosciences
IDXG
|
96 | $ 1.6 | -3.03 % | $ 7.08 M | USA |
 |
Illumina
ILMN
|
204 | $ 160.97 | -3.15 % | $ 25 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M |  China |
 |
National Research Corporation
NRC
|
29.4 | $ 18.79 | - | $ 421 M | USA |
 |
Natera
NTRA
|
48.3 | $ 212.07 | -3.27 % | $ 29 B | USA |
 |
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | China |
 |
Pacific Biosciences of California
PACB
|
244 | $ 1.31 | -2.96 % | $ 393 M | USA |
 |
Lantheus Holdings
LNTH
|
121 | $ 104.52 | 0.19 % | $ 7.05 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 187.51 | -0.29 % | $ 9.29 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 467.34 | -1.63 % | $ 13.5 B | USA |
 |
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 131.49 | -0.86 % | $ 23.3 B |  Schweiz |
 |
NeoGenomics
NEO
|
102 | $ 11.15 | -2.79 % | $ 1.43 B | USA |
 |
Myriad Genetics
MYGN
|
95.1 | $ 4.33 | -6.48 % | $ 401 M | USA |
 |
Personalis
PSNL
|
63.8 | $ 9.59 | 1.8 % | $ 856 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 26.46 | 1.34 % | $ 25.1 B |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
96.1 | $ 76.17 | 2.86 % | $ 4.56 B | USA |
 |
Senseonics Holdings
SENS
|
104 | $ 7.18 | -2.05 % | $ 300 M | USA |
 |
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
1.04 K | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
204 | $ 2.05 | -1.91 % | $ 4.71 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 266.16 | 0.34 % | $ 22.1 B | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 469.34 | -1.33 % | $ 177 B | USA |
 |
Trinity Biotech plc
TRIB
|
299 | $ 0.65 | -3.7 % | $ 233 M |  Irlanda |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
213 | $ 9.1 | -1.57 % | $ 1.97 B | USA |
 |
Invitae Corporation
NVTA
|
368 | - | - | $ 21.2 M | USA |